Diligence memo · auto-generated · as of July 2, 2026
Arizona Isotopes Science Research Corp.
Arizona Isotopes Science Research Corp. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Arizona Isotopes Science Research Corp. operates in Pharmaceuticals, based in BUNKER HILL.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Arizona Isotopes Science Research Corp. has raised $100M in disclosed capital across 2 recorded rounds, aggregated from public filings. Its latest round is modeled as Series C (a $40M–$100M round).
Largest single filing: $58M on 2018-05-16.
Most recent recorded round closed around 2018-05-16.
Valuation (modeled)modeled
Provath models Arizona Isotopes Science Research Corp. at approximately $2.0B (range $189M–$5.4B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.88× the median modeled value of Series C Pharmaceuticals companies in 2016–2018 (32 peers) — value vs value, same stage and era. Within the normal band (88% of peer median) for its niche.
Financing rhythm & timingmixed
Last raise 8.1 yr ago; this sector typically re-raises about every 13 months.
Silent for over 3× the sector's normal cadence.
The last round stepped up 1.3× from the prior — scaling.
Comparablesmixed
Capital scale ranks ahead of 91% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 94% of those peers.
Closest niche peers: Amplyx Pharmaceuticals, Inc., Ligand Pharmaceuticals Inc, Homology Medicines, Inc., KSQ Therapeutics, Inc., TP Therapeutics, Inc..
Peoplefiled
16 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.